載入...
Cladribine with immediate rituximab for the treatment of patients with variant hairy cell leukemia
PURPOSE: In contrast to the classic form, variant hairy cell leukemia (HCLv) responds poorly to single-agent purine analogs, expresses unmutated BRAF, has shorter overall survival, and lacks effective standard therapy. No treatment has achieved a high complete remission rate even in small series, an...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3867590/ https://ncbi.nlm.nih.gov/pubmed/24277451 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-1752 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|